• Citer

Resistance at virological failure using boosted protease inhibitors versus nonnucleoside reverse transcriptase inhibitors as first-line antiretroviral therapy - Implications for sustained efficacy of ART in resource-limited settings

par Hill, Andrew;McBride, Angela;Sawyer, William A.W.;Clumeck, Nathan ;Gupta, Ravindra R.K.
Référence The Journal of infectious diseases, 207, SUPPL.2, page (S78-S84)
Publication Publié, 2013-06

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Resistance at virological failure using boosted protease inhibitors versus nonnucleoside reverse transcriptase inhibitors as first-line antiretroviral therapy - Implications for sustained efficacy of ART in resource-limited settings
Auteur:	Hill, Andrew; McBride, Angela; Sawyer, William A.W.; Clumeck, Nathan; Gupta, Ravindra R.K.
Informations sur la publication:	The Journal of infectious diseases, 207, SUPPL.2, page (S78-S84)
Statut de publication:	Publié, 2013-06
Sujet CREF:	Allergie et immunopathologie
	Pathologie maladies infectieuses
Mots-clés:	antiretroviral therapy
	ART
	HIV
	NNRTI
	PI
	protease
	resistance
	reverse transcriptase
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0022-1899
	info:doi/10.1093/infdis/jit112
	info:scp/84878319894
	info:pmid/23687293